相关实验视频

Updated: Jul 15, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.1K

CD19向的化学抗原受体T细胞疗法用于同时扩散大B细胞淋巴瘤和多发性髓瘤

Tyler D'Ovidio1, Kathryn Ciccolini1, Matko Kalac1

  • 1Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.

Cureus
|October 4, 2023
PubMed
概括

本病例报告详细介绍了一种罕见的同时发生多发性骨髓瘤 (MM) 和扩散性大B细胞淋巴瘤 (DLBCL) 的病例. 针对CD19的CAR T细胞疗法成功治疗了这两种血液性恶性瘤.

关键词:
汽车T细胞治疗同时出现的恶性瘤.扩散的大B细胞淋巴瘤多发性骨髓瘤是多发性骨髓瘤的一种疾病.其他非霍奇金淋巴瘤.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551